These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 19061596

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Segmental tuberous sclerosis presenting as unilateral facial angiofibromas.
    Trauner MA, Ruben BS, Lynch PJ.
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S164-6. PubMed ID: 12894111
    [Abstract] [Full Text] [Related]

  • 4. Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.
    Tyburczy ME, Wang JA, Li S, Thangapazham R, Chekaluk Y, Moss J, Kwiatkowski DJ, Darling TN.
    Hum Mol Genet; 2014 Apr 15; 23(8):2023-9. PubMed ID: 24271014
    [Abstract] [Full Text] [Related]

  • 5. Facial angiofibromas in a mosaic pattern tuberous sclerosis: A case report.
    Alshaiji JM, Spock CR, Connelly EA, Schachner LA.
    Dermatol Online J; 2012 Jul 15; 18(7):8. PubMed ID: 22863630
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dermacase. Tuberous sclerosis (Bourneville's disease).
    Adams SP.
    Can Fam Physician; 1998 Jun 15; 44():1251, 1257. PubMed ID: 9640517
    [No Abstract] [Full Text] [Related]

  • 9. Unilateral angiofibromas. An oligosymptomatic and segmentary form of tuberous sclerosis.
    Del Pozo J, Martínez W, Calvo R, Almagro M, Fonseca E.
    Eur J Dermatol; 2002 Jun 15; 12(3):262. PubMed ID: 11989480
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.
    Wheless JW, Almoazen H.
    J Child Neurol; 2013 Jul 15; 28(7):933-6. PubMed ID: 23680945
    [Abstract] [Full Text] [Related]

  • 16. Erythematous papules on the face.
    Buck S, Bunt C.
    Am Fam Physician; 2012 Dec 01; 86(11):1065-7. PubMed ID: 23198674
    [No Abstract] [Full Text] [Related]

  • 17. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
    Hofbauer GF, Marcollo-Pini A, Corsenca A, Kistler AD, French LE, Wüthrich RP, Serra AL.
    Br J Dermatol; 2008 Aug 01; 159(2):473-5. PubMed ID: 18547304
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Segmental tuberous sclerosis in a patient presenting as unilateral facial angiofibromas, periungual fibromas and Shagreen patch.
    Sener S, Sasmaz S.
    Eur Rev Med Pharmacol Sci; 2011 Aug 01; 15(8):980-2. PubMed ID: 21845812
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.